Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Histopathology
|
June 14, 2021
Combined histopathological risk score using TP53 protein expression, CD8<sup>+</sup> T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma
Wei Chen, Lama Farchoukh, Lindsey Seigh, et al.
The American Journal of Surgical Pathology
|
July 21, 2016
MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas
Lama Farchoukh, Shih-Fan Kuan, Beth Dudley, et al.
Diabetes
|
April 6, 2013
β-Cell lipotoxicity in response to free fatty acid elevation in prepubertal youth: African American versus Caucasian contrast
Sara F Michaliszyn, Riccardo C Bonadonna, Lindsey A Sjaarda, et al.
Pediatric Diabetes
|
January 23, 2016
Differences in β-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role?
Sara F Michaliszyn, SoJung Lee, Fida Bacha, et al.
American Journal of Clinical Pathology
|
December 12, 2019
Multifocal Extraprostatic Extension of Prostate Cancer
Lama Farchoukh, William A Laframboise, Joel B Nelson, et al.
Diabetes Care
|
August 23, 2012
HbA(1c) diagnostic categories and β-cell function relative to insulin sensitivity in overweight/obese adolescents
Lindsey A Sjaarda, Sara F Michaliszyn, SoJung Lee, et al.
Diabetes
|
June 21, 2014
β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes
Sara F Michaliszyn, Andrea Mari, SoJung Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 15, 2020
Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma
Lama Farchoukh, Douglas J Hartman, Changqing Ma, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Histopathology
|
June 14, 2021
Combined histopathological risk score using TP53 protein expression, CD8<sup>+</sup> T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma
Wei Chen, Lama Farchoukh, Lindsey Seigh, et al.
The American Journal of Surgical Pathology
|
July 21, 2016
MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas
Lama Farchoukh, Shih-Fan Kuan, Beth Dudley, et al.
Diabetes
|
April 6, 2013
β-Cell lipotoxicity in response to free fatty acid elevation in prepubertal youth: African American versus Caucasian contrast
Sara F Michaliszyn, Riccardo C Bonadonna, Lindsey A Sjaarda, et al.
Pediatric Diabetes
|
January 23, 2016
Differences in β-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role?
Sara F Michaliszyn, SoJung Lee, Fida Bacha, et al.
American Journal of Clinical Pathology
|
December 12, 2019
Multifocal Extraprostatic Extension of Prostate Cancer
Lama Farchoukh, William A Laframboise, Joel B Nelson, et al.
Diabetes Care
|
August 23, 2012
HbA(1c) diagnostic categories and β-cell function relative to insulin sensitivity in overweight/obese adolescents
Lindsey A Sjaarda, Sara F Michaliszyn, SoJung Lee, et al.
Diabetes
|
June 21, 2014
β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes
Sara F Michaliszyn, Andrea Mari, SoJung Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 15, 2020
Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma
Lama Farchoukh, Douglas J Hartman, Changqing Ma, et al.
Page
of 1